Just hold, same tactic from sharks and IBs again, make it limit up then everyone coming to buy, on the second day morning sure a lot of sellings due to profit taking and it form a V shaped recovery in afternoon. Just hold it la, no worries lol
Why KPJ is next gem for post covid-19? Based on Fundamental analysis our current PE guideline is approx 57.14 (Based on 1.75% of BNM base rate) however KPJ PE=17.47@RM0.83 thus the actual price for KPJ should be RM2.71. Covid-19 only good for medical sector (more clearly is protective medical equipment “glove, mask, face shield and etc” and diagnosis instrument “thermo scanners, PCR tester and etc” For Malaysia top glove, harta, kossan and supermx all are the first round winners. For the last stage of vaccination development, now is the time to look for the next gem but unfortunately our country is impossible to produce these vaccine. The only vaccine we can get is import and we hv 20+mil ppl need to be vaccinated. Early stage of vaccine must be very expensive and gov won’t sponsor. We only can get vaccinated through private hospital no matter for travel or job requirement or just stay safe. Based on 2019, KPJ recorded 2,629,878 outpatients @ net profit 226.7mil with 28 hospitals overall the state. If half of 20mil ppl go KPJ for vaccination so approx net profit can reach up to 1bil. And u need to know tat those vaccine isn’t 1 injection for lifetime (like seasonally flu vaccine) and must get it semi or annually. RM1k-2k per vaccine per yrs for everyone to stay safe is new normal of post covid-19. And it is long term investment value of KPJ.
There are 23 potential vaccines developed and 3 candidates already passed the clinical trial and go for final stage of testing. 1. Moderna vaccine enter the final stage of human trials for its COVID-19 vaccine on July 27. 2. Oxford-AstraZeneca Covid-19 vaccine show good immune responses without side effect. 3. Chinese-made vaccine from Sinovac Biotech at final stage of testing in Brazil.
Poor kid xcaliberak like to follow me .. lastime giv u call buy at scomnet at 0.700 highest rm1.6 ...say I hardcore promoter ... u think I so powerful meh stupid...you see yspsah 1 day show nia trap ppl lah you...boh chow c a... retard follow my call if you wanna earn money .. buy cal plabs 0.235 highest 0.32... what u wanna to complain ... go and bang your head and look lah
Xcaliberak where are you hiding in sand now izit... omg goodness my topglove rm26.12 ... wow ... tell you don’t always bicker with me ... guys remember donate some of your wealth to unfortunate ppl ... god bless us...
Thank you. I will hold and Q again at lower price to bring down my average cost.
@Iamnotasifu Just hold, same tactic from sharks and IBs again, make it limit up then everyone coming to buy, on the second day morning sure a lot of sellings due to profit taking and it form a V shaped recovery in afternoon. Just hold it la, no worries lol
A vaccine in development by the British-Swedish company AstraZeneca and the University of Oxford is based on a chimpanzee adenovirus called ChAdOx1. Their Phase I/II trial, reported on July 20 in the journal Lancet, found that the vaccine was safe, causing no severe side effects. It raised antibodies against the coronavirus as well as other immune defenses. The vaccine is now in a Phase II/III trial in England, as well as Phase III trials in Brazil and South Africa. The project may deliver emergency vaccines by October. AstraZeneca has said their total manufacturing capacity for the vaccine, if approved, stands at two billion doses.
The German company BioNTech has entered into collaborations with Pfizer, based in New York, and the Chinese drug maker Fosun Pharma to develop their mRNA vaccine. In July, they posted preliminary results from their Phase I/II trials in the United States and Germany. They found that the volunteers produced antibodies against SARS-CoV-2, as well as immune cells called T cells that respond to the virus. Some volunteers experienced moderate side effects such as sleep disturbances and sore arms.
The company expects to start Phase III trials by the end of July. On July 22, the Trump administration awarded a $1.9 billion contract for 100 million doses to be delivered by December and the option to acquire 500 million more doses. If approved, Pfizer said they expect to manufacture over 1.3 billion doses of their vaccine by the end of 2021.
Got in today YSP at 2.67. Was looking at duopharma last wk but missed out at 2.7+. But saw YSP valuations seem cheaper than the duo, kontra and the rest.
good counter to invest no matter long term or short term, long term invest to earn dividend compared bank interest which lower now. short term invest if vaccine is available, investor favor hearth care counter
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Iamnotasifu
678 posts
Posted by Iamnotasifu > 2020-07-23 12:13 | Report Abuse
Just hold, same tactic from sharks and IBs again, make it limit up then everyone coming to buy, on the second day morning sure a lot of sellings due to profit taking and it form a V shaped recovery in afternoon. Just hold it la, no worries lol
@pingoboy bought at 2.9. should hold?